E and P Discourse
E and P Discourse
UNIT I
1
Enzymes are biological catalysts that speed up chemical reactions by lowering the activation
energy. Imagine a scenario where an enzyme is introduced into a reaction but fails to increase the
reaction rate. Find the potential reasons for this and address them.
Ans:
• Incorrect pH/Temperature
• Low Enzyme Concentration
• Low Substrate Concentration
• Enzyme Inhibitors
• Enzyme Denaturation
• Substrate-Enzyme Mismatch
Match the protein structure levels with their characteristics and functions:
2.
Ans:
A1-B1-C1
A2-B2-C2
A3-B3-C3
A4-B4-C4
A team of researchers is developing a drug to precisely control the activity of a crucial metabolic enzyme
3. involved in energy production. Guided by the concept of allosteric regulation, they aim to design a
molecule that can either enhance or suppress enzyme activity by binding to a specific allosteric site. Their
goal is to fine-tune metabolic processes to address conditions related to energy imbalances, such as
metabolic disorders or mitochondrial dysfunction. Based on your knowledge and understanding of
allosteric regulation, infer whether the drug should act as an allosteric activator or inhibitor to address
an energy imbalance in cells.
Ans:
If the goal is to increase energy production, the drug should act as an allosteric activator.
If the goal is to reduce excess energy production, it should act as an allosteric inhibitor.
Find the group A and group B, given in the figure “Basic structure of Amino acids” which consists
of a central carbon atom, also known as the alpha (α) carbon, bonded to a group ‘A’, group ‘B’ and
4. a hydrogen atom. Group A contains nitrogen, often linked with basic properties, while group B
contains both carbon and oxygen, contributing acidic characteristics.
Ans:
In a biochemical pathway, the enzyme fumarase, a type of lyase, catalyzes the conversion
5. of fumarate to L-malate. A team of researchers is investigating how to regulate fumarase activity
to influence metabolic flux in energy production pathways. By studying the enzyme’s structure
and potential regulatory sites, they aim to develop a molecule that can either enhance or inhibit
fumarase function, providing potential therapeutic strategies for metabolic disorders.Consider a
scenario where a Lactase replaces fumarase in the reaction in the figure “Fumarate’s conversion
to L-malate”, Infer whether the reaction would still proceed efficiently or if an alternative
product might form
Ans:
• In feedback inhibition, Initialy the substrate moves sequentially through enzymes, forming
intermediate products that lead to the end product.
• When the end product accumulates, it binds allosterically to an earlier enzyme, reducing
its activity.
• This halts excess production, ensuring metabolic balance and efficient resource use.
7. A team of researchers is studying enzyme-substrate interactions to design a drug that can either
enhance or inhibit the activity of a target enzyme involved in a metabolic pathway. The Figure
shows two models of enzyme-substrate binding: A-the lock-and-key model (rigid fit) and the
B- induced-fit model (dynamic conformational change).
Figure:Enzyme Components
i) Explain why the purified enzyme is inactive initially and what changes occur to make
it functional. What would this functional complex be called?
ii) In the glucose metabolism. It’s products are Pyruvic acid, ATP and NADH.
Now, due to some malfunction the conversion of NADH to NAD+ is stopped. Give the
impact of this NAD+ reduction in glucose metabolism and discuss about this.
Ans:
i) The purified enzyme is inactive because it lacks its required cofactor (e.g., a
coenzyme), existing as an apoenzyme. When the cofactor binds, it forms the
active holoenzyme complex, enabling catalysis at the catalytic site.
ii) If NAD⁺ is not regenerated, glycolysis halts because NAD⁺ is essential for oxidizing
glyceraldehyde-3-phosphate, leading to decreased ATP production.
9. An artificial enzyme is a synthetic organic molecule or ion that recreates one or more functions of
an enzyme. It seeks to deliver catalysis at rates and selectivity observed in naturally occurring
enzymes.
Figure : Artificial enzymes
1. Predict if we can use artificial enzymes in natural environment just like natural enzymes?
2. Which of the following is not true for synzymes?
a) They are referred to as artificial enzymes
b) They possess two structural entities which are a substrate binding site and a
catalytically effective site
c) They do not obey the Michealis-Menten kinetics
d) Producing catalytic site is difficult
Ans:
1. Artificial enzymes (e.g., nanozymes, semi-artificial enzymes) can function in natural
environments but often with reduced specificity or stability compared to natural
enzymes. Their success depends on design precision and environmental compatibility.
2. Option c) is not true for synzymes. Like natural enzymes, most synzymes obey Michaelis-
Menten kinetics.
(Key points: Artificial enzymes work but may lack natural efficiency; synzymes follow enzyme
kinetics.)
UNIT II
1. 1. Match the following enzymes with their stereospecificity and the type of substrate they
act on:
Ans:
A1-B1-C1
A2-B2-C2
A3-B3-C3
A4-B4-C4
Ans: d)1, 2, 4, 3, 5, 6
3. A research team is purifying a mixture of proteins to isolate a target protein essential for a drug
formulation using ion exchange chromatography. They employ a cation exchange column, which
carries negatively charged functional groups. As the protein mixture passes through the column,
proteins with a net positive charge bind strongly to the resin, while negatively or neutrally charged
proteins elute quickly. To achieve optimal separation, the team gradually increases the salt
concentration or adjusts the pH of the elution buffer, selectively displacing bound proteins based
on their charge properties. By fine-tuning these conditions, they aim to isolate the desired protein
with high purity and yield for pharmaceutical applications.
Refer to Figure “The Two Kinds of Ion Exchangers”, and compute the steps to be taken from the
team to recover the protein from the column when the desired protein binds to the cation
exchanger and does not elute with the initial buffer.
4. Consider you are preparing a dessert that requires milk. The milk contains lactose, which cannot
be directly used as energy by your body. Instead, lactase, an enzyme in your digestive system,
breaks down lactose into simpler sugars that can be absorbed. Based on this scenario, explain the
reason for lactose is considered a substrate and not an enzyme, while lactase is recognized as an
enzyme.
Ans:
• Lactose is considered a substrate because it is the compound being broken down during
the reaction.
• Lactase is recognized as an enzyme because it catalyzes the breakdown of lactose into
glucose and galactose, making the sugars absorbable by the body. Enzymes like lactase act
on substrates like lactose.
Ans:
A) Both Assertion and Reason are correct, and the Reason correctly explains the Assertion.
7. Milk is a valuable source of nutrients containing protein, fat and the carbohydrate lactose. 5-10%
of the UK population are lactose intolerant. Lactose is a disaccharide that is broken down into
glucose and galactose by the enzyme lactase. (figure)
Ans:
A1-B3-C2-D3
A2-B1-C4-D2
A3-B2-C3-D1
A4-B4-C1-D4
2. You are studying the lactate dehydrogenase (LDH) enzyme, which catalyzes the conversion of
pyruvate to lactate in an ordered sequential mechanism.
Refer to the figure “Reaction of the lactate dehydrogenase: pyruvate (left) is oxidized to lactate
(right) by expense of NADH”. Based on the sequential binding and release process, compute the
order of substrate binding and product release affects the enzyme’s catalytic efficiency.
Figure : Reaction of the lactate dehydrogenase: pyruvate (left) is oxidized to lactate (right) by
expense of NADH
Ans:
Order of Substrate Binding & Product Release in LDH Reaction:
1. Binding Order:
• NADH binds first (required to activate the enzyme’s catalytic site).
• Pyruvate binds second (substrate positioning for reduction).
2. Catalysis:
• NADH reduces pyruvate → lactate, while NAD⁺ is formed.
3. Release Order:
• Lactate is released first (product of the reaction).
• NAD⁺ is released last (cofactor dissociation completes the cycle).
Effect on Catalytic Efficiency:
✓ Ensures precise alignment for catalysis.
✓ Prevents wasteful binding or incorrect products.
✓ Enhances reaction speed and specificity.
3. A biotechnology company is developing a new industrial process that requires the use of
immobilized enzymes for the synthesis of high-value chemicals. The company is considering
different enzyme immobilization techniques, as shown in the figure titled “Enzyme immobilization
techniques,” to optimize enzyme stability and activity.
Ans:
a) Covalent binding
b) Ionic binding
c) Cross-linking
d) Encapsulation
4. You are tasked with optimizing an enzyme’s activity for industrial production. The enzyme shows
peak activity at pH 7.2 to 7.4. However, when the pH rises above 7.5, enzyme activity declines
significantly, and when the pH drops below 7.1, microbial growth becomes uncontrollable.
Additionally, previous experiments have shown that slight fluctuations outside this range have led
to enzyme denaturation or excessive microbial contamination.
Parse a strategy to determine the ideal pH range for maximum enzyme activity and minimal
microbial growth
Ans:
1. Narrow pH Testing: Conduct experiments in small increments (e.g., pH 7.0–7.6) to
pinpoint the exact range where:
• Enzyme activity is ≥90% of peak (likely pH 7.2–7.4).
• Microbial growth is suppressed (pH <7.2 inhibits contaminants).
2. Stability Assays: Incubate the enzyme at candidate pHs (e.g., 7.2, 7.3, 7.4) and measure:
• Activity retention over time (avoid denaturation).
• Microbial counts (ensure pH ≤7.4 prevents contamination).
3. Optimal Compromise: Select the highest pH within 7.2–7.4 that balances:
• Maximal enzyme activity.
• Minimal microbial growth (closer to 7.4 preferred).
4. Buffer System: Use a high-capacity buffer (e.g., HEPES) to maintain pH strictly within ±0.1
units of the chosen value.
Simplify answer:
• Maintain pH between 7.2 and 7.4 for peak enzyme activity.
• Implement buffer systems to prevent fluctuations.
• Regularly monitor contamination risks at lower pH levels.
5. A pharmaceutical company is evaluating a newly developed immobilized enzyme system to
improve enzyme stability and reusability in drug synthesis. Researchers analyze the reaction rates
of free and immobilized enzymes at varying substrate concentrations, as shown in the provided
table titled “Reaction rate comparison: Free versus immobilized enzymes.”
Justify the differences in reaction rates between the two enzyme types, emphasizing the impact
of diffusion limitations on enzyme activity at different substrate concentrations.
Table - Reaction rate comparison: Free versus immobilized enzymes
Ans:
• The free enzyme shows a faster increase in reaction rate with substrate concentration
due to unrestricted substrate access.
• The immobilized enzyme shows lower rates, especially at higher concentrations, due to
diffusion limitations—substrates take longer to reach the enzyme trapped in the matrix.
• This mass transfer resistance reduces the apparent enzyme efficiency at higher substrate
levels. Thus, immobilization limits reaction rate due to slower substrate-enzyme
interaction.
UNIT IV
1. Select the most appropriate answer after analyzing the following statements:
Assertion (A): Cooperative binding in hemoglobin depends on its quaternary structure.
Reason (R): Conformational shifts responsible for allosteric effects in hemoglobin occur solely
within individual globin chains.
a) Both A and R are true, and R explains A
b) Both A and R are true, but R does not explain A
c) A is true, but R is false
d) A is false, but R is true
Ans:
c) A is true, but R is false
2. You are comparing the heat-induced unfolding behavior of two proteins, Protein X and Protein Y,
using their thermal denaturation profiles shown in the figure titled “Thermal denaturation
profiles.” Protein X shows a gradual loss of structure, with 50% remaining at 60°C and complete
denaturation at 75°C. In contrast, Protein Y maintains 70% of its structure at 60°C but undergoes
a sharp structural loss after 65°C, becoming fully denatured by 85°C.
Ans:
Protein Refolding Potential
Prediction: Protein Y has a higher potential for successful refolding.
Ans:
(c) Team 3 (glycerol + chaperones) is likely to yield the highest restoration of enzymatic function.
Justification:
• Glycerol stabilizes partially unfolded intermediates, preventing aggregation.
• Molecular chaperones actively assist in proper refolding.
Combining glycerol, which stabilizes partially unfolded intermediates, with molecular
chaperones, which assist in correct refolding, provides synergistic support for restoring the
enzyme’s native structure more effectively than either method alone.
4. A pharmaceutical company is investigating the binding efficiency and therapeutic potential of
three ligands—Ligand A, Ligand B, and Ligand C—each targeting the same immune-related cell
surface receptor. Their dissociation constants (Kd) indicate differing binding affinities:
Ligand A: Kd = 10⁻8 M, Ligand B: Kd = 10⁻6 M and Ligand C: Kd = 10⁻4 M.
Each ligand is initially tested at a concentration of 10⁻6 M to assess pharmacodynamic
responses.
a) Identify the ligand expected to maintain receptor occupancy the longest and support your
reasoning.
b) Identify the ligand likely to achieve rapid receptor engagement and provide justification.
c) Identify the ligand expected to show minimal activity when the concentration is decreased to
10⁻4 M and justify the prediction.
Ans:
a) Ligand A – It has the lowest Kd (10⁻⁸ M), indicating highest affinity, so it binds more tightly
and maintains receptor occupancy the longest.
b) Ligand C – It has the highest Kd (10⁻⁴ M), so at 10⁻⁶ M, it's at 100-fold higher than its Kd,
leading to rapid receptor engagement due to excess ligand.
c) Ligand C –it has the highest Kd (10⁻⁴ M) , it show minimal activity and lower concentration
dreastically reduce activity.
5. During a thermal stability experiment, a protein that usually exhibits a slow, progressive rise in
absorbance at 280 nm shows an unexpected abrupt transition at a certain temperature. Evaluate
the underlying factors responsible for this sudden cooperative unfolding event and analyze its
consequences on the integrity of the protein’s tertiary structure.
Ans:
Factors responsible:
• Cooperative unfolding due to disruption of stabilizing interactions (e.g., hydrogen bonds,
hydrophobic core).
• Threshold energy exceeded, triggering simultaneous destabilization of multiple domains.
• Loss of non-covalent interactions maintaining tertiary structure.
• Possible involvement of oligomeric interfaces if the protein is multimeric.
Consequence:
• Abrupt loss of tertiary structure, leading to exposure of hydrophobic regions,
aggregation, and irreversible denaturation.
6. A research team is designing a modular protein composed of four functional domains—Domain
1 (responsible for binding), Domain 2 (catalytic core), Domain 3 (regulatory unit), and Domain 4
(providing structural integrity), as depicted in the figure titled “Protein Architecture”.
Ans:
a) Oxidation of cysteine residues in Domain 3:
May form disulfide bonds, potentially altering regulatory control—could enhance or inhibit
domain flexibility and responsiveness.
b) Strengthening hydrophobic interactions (Domains 1 & 2):
Improves domain coupling, likely enhancing substrate binding and catalysis, thus boosting
overall activity.
c) Suppression of glycosylation (Domain 4) + urea exposure (Domain 2):
Leads to reduced structural stability (Domain 4) and partial unfolding/inactivation of catalytic
function (Domain 2), compromising protein integrity and function.
Overall impact: Mixed effects—functional enhancement from (a) and (b), but structural and
catalytic destabilization from (c) may reduce net protein activity.
UNIT V
1. As the lead investigator in an enzyme modification program, you are tasked with tailoring the
substrate specificity of three key serine proteases—elastase, chymotrypsin, and trypsin—for
targeted catalytic enhancements. The intended modifications aim to enable elastase to act on
basic substrates, optimize chymotrypsin for small hydrophobic molecules, and increase trypsin’s
affinity for aromatic residues without compromising its substrate selectivity.
a) Evaluate the structural and catalytic barriers associated with engineering elastase to
accommodate basic residues in its active site.
b) Assess the enzymatic consequences of altering the volume of chymotrypsin’s substrate-
binding pocket—both in terms of reduction and expansion.
c) Identify the design challenges linked to enhancing trypsin’s interaction with aromatic residues
while maintaining its native specificity profile.
Ans:
a) Elastase modification barriers:
Requires enlarging its narrow, hydrophobic S1 pocket and introducing negatively charged
residues to bind basic substrates—risk of disrupting active site geometry and catalytic
efficiency.
b) Chymotrypsin pocket volume changes:
• Reduction: Impairs binding of bulky substrates, reducing activity.
• Expansion: Decreases specificity, may allow non-specific binding, lowering catalytic
precision.
c) Trypsin design challenges:
Introducing features for aromatic binding (e.g., hydrophobic/aromatic residues) must not
disrupt its Asp189-mediated specificity for basic residues—balancing dual affinity without loss
of selectivity is structurally complex.
2. Evaluate the following statements and choose the most appropriate option:
Statement I: Catalytic antibodies (abzymes) are capable of replicating the enzymatic activity
exhibited by serine proteases through engineered active sites.
Statement II: The catalytic mechanism of abzymes primarily involves stabilization of the
transition state by their antigen-binding (variable) regions.
a) Both statements are correct, and Statement II explains Statement I
b) Both statements are correct, but Statement II does not explain Statement I
c) Statement I is correct, but Statement II is incorrect
d) Statement I is incorrect, but Statement II is correct
Ans: (a) Both statements are correct, and Statement II explains Statement I
3. A pharmaceutical team is developing an antibody-drug conjugate (ADC) using an IgG molecule,
illustrated in the figure titled “IgG structure,” which highlights the Fab, Fc, and hinge regions.
They are assessing suitable sites for attaching the drug to ensure optimal therapeutic function.
Ans:
a) Preferred site: Fc region – Conjugation here avoids interfering with the Fab region, thus
preserving antigen recognition.
b) Impact of hinge region attachment:
May reduce structural flexibility, potentially hindering Fab movement and antigen-binding
efficiency, especially for targets requiring conformational adaptability.
4. A group of enzymologists is analyzing the activity of native trypsin, modified trypsin, and
elastase on substrates with positive charges, as illustrated in the figure titled “Enzyme
structures.” The modified form of trypsin shows a catalytic efficiency of 120%, which is 40%
higher than the native version (80%), whereas elastase operates at only 40% efficiency.
Ans:
a) Engineered trypsin likely has modifications (e.g., mutations in the substrate-binding pocket or
active site) that enhance substrate affinity or catalytic turnover, increasing efficiency by 40%.
b) Elastase has a narrower binding pocket with bulky residues that hinder access to positively
charged substrates, reducing its catalytic efficiency compared to trypsin.
6. Researchers at a biotechnology institute are evaluating the structural integrity of IgG antibodies,
referring to the figure titled “Structure of IgG antibody.” Their investigation focuses on the
reduction of disulfide linkages that connect the heavy and light chains.
Ans:
Disrupting the inter-chain disulfide bonds in IgG would:
1. Destabilize the antibody's quaternary structure, leading to misalignment of heavy and
light chains.
2. Reduce antigen-binding affinity due to improper positioning of the Fab regions, critical for
epitope recognition.
Changes in antigen-binding affinity:
The antibody's overall structure would destabilize, causing it to unfold or misfold. This disruption
would affect the antigen-binding sites, leading to a decrease or complete loss of antigen-binding
affinity, as the proper three-dimensional structure required for specific binding would no longer
be maintained.